Immunome Inc.
IMNM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001472012
In the last 90 days, Immunome Inc. insiders filed 0 open-market purchases and 8 sales; 202 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.
Superinvestors holding IMNM, Q2 2026
No superinvestor reported holding IMNM in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of IMNM each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q3 2024
0 superinvestors holding at quarter end
- Sold out
- HHLR Advisors (Hillhouse)
Q2 2024
1 superinvestor holding at quarter end